Brand New Galaxy Launches Western European Operation in Amsterdam
17.2.2021 09:00:00 EET | Business Wire | Press release
The rapidly growing global marketing and technology company, Brand New Galaxy launches their Western European Operation in Amsterdam, The Netherlands. The group’s mission is to provide highly specialized and data optimized solutions in E-commerce, Creative & Content Production, and Automation & Performance Improvement from the Dutch capital. Award-winning global marketing and advertising leader, Frank Carvalho is driving the growth of the new operation as Managing Director.
“Our mission is growth. We are growing rapidly, because we are built to drive performance via highly specialized and data optimized solutions for our clients. We deliver growth by utilizing our unique digital offerings and our global network of companies specialized in E-commerce, Creative & Content Production, and Automation & Performance Improvement. We set up our new office in Amsterdam, because the Dutch capital is growing too, becoming the new commercial hub of Europe,” says Frank Carvalho, Managing Director, Brand New Galaxy Amsterdam.
The award-winning Brand New Galaxy is a global provider of end-to-end E-commerce solutions and content production. The company offers several unique methodologies, including Robonauts Pictures E-commerce Real Feel, using production twists that makes online consumers’ product experience comparable to a physical one. Another specialized solution is their FMCC - Fast Moving Consumer Communications method that delivers a quick and scalable content production solution. Part of Brand New Galaxy’s proprietary tools is Synthrone, a modular and flexible ecosystem of automated services for content storage, creation, localization, publishing, tracking, and reporting.
“Efficient management of the entire digital ecosystem is a priority for all businesses who are looking for ways to drive their solid growth in E-commerce. Therefore, as an end-to-end E-commerce player founded on global-to-local methodology we see closer cooperation with our customers in Western Europe as a must have. Our Amsterdam office is a natural consequence of building convenient hubs for well-developed clients and those who are at the early stage of their E-commerce journey,” says Michał Glapiński, Chief Growth Officer responsible for international operations of Brand New Galaxy.
Galactic Growth
Brand New Galaxy has been growing rapidly in the last couple of years by opening new offices and acquiring new companies. Just in 2020 the group launched three offices on three continents, including the United States, the Middle East and Europe. Last year their workforce increased by almost 35 percent to more than 500 employees, with 80 percent of the professionals are working on global and regional levels. They supply global and local services to over 200 clients in 29 languages, from Fortune 500 companies to E-commerce players from small-to-medium-sized businesses. Brand New Galaxy is a three-time winner of the prestigious Press Magazine Awards.
Galactic Talent
Brand New Galaxy’s new Western European operation has a truly global leader. Frank Carvalho, Managing Director has more than 25 years of experience in marketing and advertising from all over the World, including the United States, the United Kingdom, Germany, Poland, Hungary and Australia. He is moving to Amsterdam from New York City, where he was the leader of Account Management in North America and a Global Businesses Director at Hogarth, part of WPP. Some other highlights of his multi-decade career include spending 15 years with the Publicis Groupe as Regional Client Services Director and European Business Lead on Samsung; and being the Senior Brand and Marketing Director at Vodafone in Czech Republic. He has extensive experience in the financial, professional services, pharmaceutical, tobacco, automotive, telecommunications and media sector. He is the winner of four Cannes Lions Awards.
About Brand New Galaxy
Brand New Galaxy is a fast-growing, independent holding of marketing and technology agencies. The privately-owned “independent marketing platform” was founded in Warsaw, Poland in 2017 and has grown to 500+ employees to date. Brand New Galaxy invests in innovative and dynamic ideas that thrive in a start-up environment and are scalable to compete with network agencies. Brand New Galaxy is a member of the MDC Global Affiliates program. Named “Debut of the Year 2018”, “Success of the Year 2019”, “Success of the Year 2020” BNG scores first places in a prestigious agency ranking by PRESS magazine.
Brand New Galaxy companies include:
Pathfinder 23 – global E-commerce agency; Life on Mars – beauty & fashion production agency; Spacecamp – global digital agency; Synthrone - E-commerce automation and implementation platform; Voyager - E-business delivery agency; New Gravity - software & direct-to- consumer house; Robonauts Pictures - E-commerce production house; content26 - Amazon content & advertising, Man on the Moon - HR Agency; BNG MEA – Dubai based hub driving commerce in MEA region; Brand New Galaxy AMS – Amsterdam based hub igniting growth for businesses in Western Europe.
More information:
Web: ams.brandnewgalaxy.com
Downloads: BNG AMS MEDIA
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210216006090/en/
Contact information
Jagoda Prętnicka
Head of Communications
Brand New Galaxy
(+48) 506 780 846
j.pretnicka@brandnewgalaxy.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 11:28:00 EEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
